Correlation Between Changes in Sex Hormone Levels and Stress Urinary Incontinence in Women

Sponsor
RenJi Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06109623
Collaborator
(none)
1,226
16

Study Details

Study Description

Brief Summary

The goal of this observational study is to learn about the relationship between stress urinary incontinence and endogenous steroids in women, especially its occurrence and severity with androgens and estrogens. The main questions it aims to answer are:

  • Association between stress urinary incontinence and endogenous steroids in women

  • Risk factors associated with stress urinary incontinence in women Participants will be asked to provide basic clinical information as well as results of measurements of serum steroid hormone levels.

Researchers will compare Stress urinary incontinence group and control group to see if the changes of sex hormone levels were statistically significant.

Condition or Disease Intervention/Treatment Phase
  • Other: observation
  • Other: sex hormone

Detailed Description

By comparing the differences of six hormones between female patients with stress urinary incontinence (SUI) and non-SUI patients (patients without pelvic floor muscle dysfunction and lower urinary tract dysfunction) aged ≥20 years, especially the changes of androgen and estrogen levels, the correlation between the changes of hormone levels and stress urinary incontinence was obtained. Multivariate logistic regression analysis was used to analyze the relationship between hormones and urinary incontinence, and further correlation analysis was performed for statistically significant hormones. Estrogen and androgen were divided into four groups: normal estrogen/normal androgen group, decreased estrogen/normal androgen group, normal estrogen/decreased androgen group, decreased estrogen/decreased androgen group. Stratified analysis was performed to analyze whether there was an interaction between the two hormones and exclude confounding effects. Finally, the data were further analyzed by sensitivity analysis of baseline characteristics, and the known risk factors were verified in this trial, including age, parity, menopausal status, genetic factors, obesity, and on this basis, the correlation between pelvic surgery history, diabetes, hypertension, smoking and stress urinary incontinence was explored.

Study Design

Study Type:
Observational
Anticipated Enrollment :
1226 participants
Observational Model:
Case-Control
Time Perspective:
Retrospective
Official Title:
Study on the Correlation Between Changes in Steroid Hormone Levels and Stress Urinary Incontinence in Women
Anticipated Study Start Date :
Nov 15, 2023
Anticipated Primary Completion Date :
Nov 15, 2023
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
SUI group

Female patients diagnosed with stress urinary incontinence in our hospital, who met the inclusion and exclusion criteria, and received six sex hormone tests.

Other: observation
To observe the changes and differences of steroid hormones between stress urinary incontinence group and control group.

Other: sex hormone
Six indicators of steroid hormones (estrogen, testosterone, follicle stimulating hormone, luteinizing hormone, pituitary prolactin, progesterone)

control group

Patients with non-stress urinary incontinence

Other: observation
To observe the changes and differences of steroid hormones between stress urinary incontinence group and control group.

Other: sex hormone
Six indicators of steroid hormones (estrogen, testosterone, follicle stimulating hormone, luteinizing hormone, pituitary prolactin, progesterone)

Outcome Measures

Primary Outcome Measures

  1. Baseline characteristics [baseline, pre-procedure]

    The results of this study were described by statistical methods. Descriptive statistical analysis was performed on the baseline characteristics of patients in the SUI group and the control group. Categorical variables were described by frequency (%), and Pearson chi-square test or Fisher Exact test was used. Continuous variables describe their mean (SD) or median data (interquartile range) according to their normality, and comparisons between groups were performed using the independent t-test (normal) or Mann Whitney test (non-normal).

  2. Association analysis between stress urinary incontinence and androgen levels [immediately after the procedure]

    The association between stress urinary incontinence and the lowest quartile of serum testosterone was examined by a weighted, multivariate logistic regression model. Odds ratios and 95% confidence intervals were calculated for each outcome of interest. All models were adjusted for age, BMI, parity, menopausal status, history of pelvic surgery, hypertension, and diabetes. Two-sided p values of 0.05 or less were considered to indicate statistical significance.

Secondary Outcome Measures

  1. Sensitivity analysis or stratified analysis [through study completion, an average of 6 month]

    The association between hormone levels and stress urinary incontinence is affected by many uncertain factors, such as population characteristics and disease history. In order to avoid bias of results caused by uncertain factors, sensitivity analysis or stratified analysis of these factors is required. This project planned to perform sensitivity or stratified analyses by grouping the subjects into multiple subgroups (grouped by age, history of childbirth, history of hypertension, history of diabetes, history of pelvic surgery, etc.).

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Experimental Group
  1. women aged ≥20 years

  2. Stress urinary incontinence diagnosed in our hospital;

  3. Six hormone tests were performed in our hospital; Control group

(1) women aged ≥20 years; (2) diseases other than stress urinary incontinence diagnosed by our hospital; (2) Six hormone tests were performed in our hospital;

Exclusion Criteria:
  1. Pelvic organ prolapse, overactive bladder, urge urinary incontinence, overflow urinary incontinence, mixed urinary incontinence;

  2. patients who received hormone replacement therapy within 6 months;

  3. estrogen-dependent diseases, such as endometriosis, uterine leiomyoma, ovarian tumors;

  4. the presence of gynecological malignant tumors or other diseases affecting hormone secretion;

  5. the presence of nervous system diseases.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • RenJi Hospital

Investigators

  • Principal Investigator: Chun-Wu Pan, professor, Renji Hospital, School of Medicine, Shanghai Jiao Tong University,

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Chun-Wu Pan, Professor, RenJi Hospital
ClinicalTrials.gov Identifier:
NCT06109623
Other Study ID Numbers:
  • IIT-2023-0135
First Posted:
Oct 31, 2023
Last Update Posted:
Oct 31, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Chun-Wu Pan, Professor, RenJi Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 31, 2023